| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 0125DUV5XC |
Pharmacology
| Action | Mechanism of Action | Reference | |
|---|---|---|---|
| AGONIST | CD27 antigen agonist | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference | ||
|---|---|---|---|---|---|
| Cholangiocarcinoma | 2 | D018281 | ClinicalTrials | ||
| Melanoma | 2 | D008545 | ClinicalTrials | ||
| Glioblastoma | 2 | D005909 | ClinicalTrials | ||
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials | ||
| Astrocytoma | 1 | D001254 | ClinicalTrials | ||
| Lymphoma | 1 | D008223 | ClinicalTrials | ||
| Urogenital Neoplasms | 1 | D014565 | ClinicalTrials | ||
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials | ||
| Oligodendroglioma | 1 | D009837 | ClinicalTrials | ||
| Oligodendroglioma | 1 | D009837 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1393344-72-3 |
| ChEMBL | CHEMBL3137347 |
| FDA SRS | 0125DUV5XC |
CONTENTS